NIH: Genetic and Metabolic Basis of Familial Lipodystrophies
Dr. Garg and his colleagues have been receiving support from NIH since 1998 to pursue these studies to find novel lipodystrophy genes and their role in human biology.
NIH: Novel Therapies for Metabolic Complications in Patients with Lipodystrophies
Since 2007, this grant has supported our studies on the role of leptin therapy and diet therapy in patients with lipodystrophy.
FDA: Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients
This grant helps us to study the safety and efficacy of cholic acid for reducing hepatic steatosis in patients with lipodystrophy.
This grant supports studies of safety and efficacy of leptin replacement therapy in patients with lipodystrophy.
Southwest Medical Foundation
This Foundation supports our studies through the Center for Human Nutrition.
We are grateful to Southwest Airlines for providing free air travel to patients from their hometowns within the United States to Dallas for evaluation and treatment at our center. Patients who meet our qualifications and cannot afford travel to our center are eligible for this program.